-+ 0.00%
-+ 0.00%
-+ 0.00%

LUNDBECK ANNOUNCES POSITIVE PHASE 2 LONG-TERM DATA FOR BEXICASERIN IN RARE CHILDHOOD-ONSET EPILEPSIES, AT AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING

Reuters·12/06/2025 17:25:51

Please log in to view news